Imipenem/cilastatin/relebactam combines older carbapenem and novel non-beta-lactam beta-lactamase inhibitor, it is approved for cUTI, cIAI, HAP and VAP in adults. The gene discussed is LACTB; the disease is ventilator-associated pneumonia.